Trial intelligence / Profile preview

Cortisol Self-administration for Rheumatic Diseases

NCT03558971Phase 4Completed

Sponsor
Helen Hay Whitney Foundation
Start
Jan 2000
Primary completion
Dec 2016
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of hydrocortisone in fibromyalgia (FM), osteoarthritis (OA), rheumatoid arthritis (RA), sponsored by Helen Hay Whitney Foundation. Started Jan 2000; status: completed.

02

Drugs

hydrocortisone
03

Conditions

fibromyalgia (FM)osteoarthritis (OA)rheumatoid arthritis (RA)

Beyond the preview

Go deeper on NCT03558971.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03558971.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call